SCHEMBL34467683

SCHEMBL34467683

N[C@@H](CCCCNC(=O)n1ncc(-c2ccc(Cl)cc2)n1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.37
▸ KMO O15229 1/20 0.35
▸ USP2 O75604 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ASAH1 Q13510 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ NOS1 P29475 2/20 0.34
▸ FOLH1 Q04609 1/20 0.34
▸ MALT1 Q9UDY8 1/20 0.34
▸ SLC6A3 Q01959 2/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34467664 0.90 NOS1 (0.41) ASAH1NOS1HDAC6ALDH1A1
SCHEMBL34467679 0.89 HDAC6 (0.38) ASAH1NOS1FOLH1HDAC1HDAC6
SCHEMBL31300285 0.83 LTA4H (0.40) LTA4HKMONOS1SMN1; SMN2
SCHEMBL34467677 0.79 L3MBTL1 (0.37) ALOX15NOS1ALDH1A1HTTL3MBTL1
SCHEMBL34467688 0.79 NOS1 (0.35) ASAH1ALOX15NOS1
SCHEMBL34467678 0.79 CAMK2D (0.37) NOS1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL34467663 0.79 BCHE (0.40) LTA4HASAH1FOLH1SLC6A3MMP2
SCHEMBL34467661 0.78 HPGD (0.35) USP2TSHRALOX15NOS1ALDH1A1
SCHEMBL34467684 0.76 OTC (0.35) NOS1
SCHEMBL25437484 0.74 GSR (0.43) TSHRNOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117274-A1 ORTHOGONALLY CROSSLINKED PROTEINS, METHODS OF MAKING, AND USES THEREOF UNIV NEW YORK STATE RES FOUND (US) 2026-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117274-A1 ORTHOGONALLY CROSSLINKED PROTEINS, METHODS OF MAKING, AND USES THEREOF PTMS, PSMG3, PSMB3 LTA4H 3361/4885KMO 2197/4885USP2 1573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback